Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer
- 1 July 2001
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (7) , 672-676
- https://doi.org/10.1038/modpathol.3880371
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- PTEN/MMAC1/TEP1 in signal transduction and tumorigenesisEuropean Journal of Biochemistry, 1999
- PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathwayProceedings of the National Academy of Sciences, 1999
- Novel PTEN mutations in patients with Cowden disease: absence of clear genotype–phenotype correlationsEuropean Journal of Human Genetics, 1999
- Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin’s lymphomaLeukemia, 1998
- Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancersOncogene, 1998
- Inhibition of Cell Migration, Spreading, and Focal Adhesions by Tumor Suppressor PTENScience, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Inherited Mutations in PTEN That Are Associated with Breast Cancer, Cowden Disease, and Juvenile PolyposisAmerican Journal of Human Genetics, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997